COVID-19 roundup: New omicron subvariants may be up to 21x more evasive against vaccine antibodies

FDA cautions that Evusheld may not be effective against the XBB.1.5 omicron subvariant, new studies suggest the coronavirus may be able to survive in infected patients even after death, and more in this week's roundup of COVID-19 news.